1. |
Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax, 2012, 67(11): 957-963.
|
2. |
Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax, 2000, 55(2): 114-120.
|
3. |
Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?. Proc Am Thorac Soc, 2004, 1(2): 109-114.
|
4. |
Serafino-Agrusa L, Scichilone N, Spatafora M, et al. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: a case-control study. Pulm Pharmacol Ther, 2016, 37: 89-94.
|
5. |
Saltürk C, Karakurt Z, Adiguzel N, et al. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?. Int J Chron Obstruct Pulmon Dis, 2015, 10: 1837-1846.
|
6. |
Couillard S, Larivée P, Courteau J, et al. Eosinophils in COPD Exacerbations are associated with increased readmissions. Chest, 2017, 151(2): 366-373.
|
7. |
Bafadhel M, Greening NJ, Harvey-Dunstan TC, et al. Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD. Chest, 2016, 150(2): 320-328.
|
8. |
费凡, 吴桢珍, 朱曼旎, 等. 血嗜酸性粒细胞在慢性阻塞性肺疾病急性加重中的临床意义. 中国呼吸与危重监护杂志, 2019, 18(5): 418-422.
|
9. |
Casanova C, Celli BR, de-Torres JP, et al. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD. Eur Respir J, 2017, 50(5): 1701162.
|
10. |
Shin SH, Park HY, Kang D, et al. Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease. Respir Res, 2018, 19(1): 134.
|
11. |
Turato G, Semenzato U, Bazzan E, et al. Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2018, 197(9): 1216-1219.
|
12. |
王景, 陈碧, 朱述阳. 入院时外周血嗜酸粒细胞百分比与慢性阻塞性肺疾病急性加重患者出院后短期内急性加重复发的关系研究. 实用心脑肺血管病杂志, 2019, 27(7): 46-50.
|
13. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013 年修订版). 中华结核和呼吸杂志, 2013, 36(4): 255-264.
|
14. |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014 年修订版). 国际呼吸杂志, 2014, 34(1): 1-11.
|
15. |
Kang HS, Rhee CK, Kim SK, et al. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2467-2473.
|
16. |
Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med, 2011, 184(6): 662-671.
|
17. |
Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax, 2005, 60(3): 193-198.
|
18. |
Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 2000, 356(9240): 1480-1485.
|
19. |
Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med, 2012, 186: 48-55.
|
20. |
薛瑾, 崔亚楠, 陈平, 等. 血嗜酸粒细胞对慢性阻塞性肺疾病急性加重期激素治疗反应性和再入院的预测价值. 中华结核和呼吸杂志, 2019, 42(6): 426-431.
|
21. |
Oh YM, Lee KS, Hong Y, et al. Blood eosinophil count as a prognostic biomarker in COPD. Int J Chron Obstruct Pulmon Dis, 2018, 13: 3589-3596.
|
22. |
Gil H, Magy N, Mauny F, et al. Value of eosinopenia in inflammatory disorders: an "old" marker revisited. Rev Med Interne, 2003, 24(7): 431-435.
|
23. |
Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax, 2012, 67(11): 970-976.
|
24. |
Holland M, Alkhalil M, Chandromouli S. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology, 2010, 15(1): 165-167.
|
25. |
Mendy A, Forno E, Niyonsenga T, et al. Blood biomarkers as predictors of long-term mortality in COPD. Clin Respir J, 2018, 12(5): 1891-1899.
|
26. |
Mao B, Lu HW, Li MH, et al. The existence of bronchiectasis predicts worse prognosis in patients with COPD. Sci Rep, 2015, 5: 10961.
|
27. |
张颖, 林英翔. 慢性阻塞性肺疾病急性加重住院患者一年及长期死亡风险因素分析. 中华结核和呼吸杂志, 2019, 42(12): 895-900.
|
28. |
García-Sanz MT, Cánive-Gómez JC, Senín-Rial L, et al. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis, 2017, 9(3): 636-645.
|